IMMUNE ACTIVATION MARKERS TO PREDICT AIDS AND SURVIVAL IN HIV-1 SEROPOSITIVES

被引:48
|
作者
FUCHS, D
JAGER, H
POPESCU, M
REIBNEGGER, G
WERNER, ER
DIERICH, MP
KABOTH, W
TILZ, GP
WACHTER, H
机构
[1] UNIV INNSBRUCK, INST MED CHEM & BIOCHEM, FRITZ PREGL STR 3, A-6020 INNSBRUCK, AUSTRIA
[2] GRAZ UNIV, DEPT INTERNAL MED, IMMUNOL & IMMUNOHAEMATOL LAB, A-8010 GRAZ, AUSTRIA
[3] UNIV INNSBRUCK, LUDWIG BOLTZMANN INST AIDS RES, A-6020 INNSBRUCK, AUSTRIA
[4] UNIV INNSBRUCK, LUDWIG BOLTZMANN INST AIDS RES, A-6020 INNSBRUCK, AUSTRIA
[5] UNIV INNSBRUCK, INST HYG, A-6020 INNSBRUCK, AUSTRIA
[6] KURATORIUM IMMUNSCHWACHE, MUNICH, GERMANY
[7] CLIN SCHWABING, DEPT INTERNAL MED, AIDS STUDY GRP, MUNICH, GERMANY
关键词
Circulating immune complex; HIV; Neopterin; Soluble CD8; Soluble IL2 receptor; Tumour necrosis factor-α;
D O I
10.1016/0165-2478(90)90178-S
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neopterin concentrations in body fluids of HIV-1 seropositives provide predictive information. In 1986, we examined serum and urine neopterin concentrations in 29 HIV-1 seropositives. Serum levels of soluble IL-2 receptor (sIL2R), soluble CD8 (sCD8), tumour necrosis factor alpha (TNF-α) and circulating immune complexes (CIC) were retrospectively analysed in 1989. All individuals had increased serum and urine neopterin, sIL2R and CIC concentrations, 27 29 had increased sCD8 concentrations, whereas all had normal TNF-α levels. During a 3-year follow-up, high urine and serum neopterin concentrations were significantly associated with progression to AIDS and with the occurrence of AIDS-associated death. Both neopterin variables were of similar predictive value (p < 0.001, generalized Wilcoxon test). sIL2R concentrations were of borderline significance in predicting the onset of AIDS (p = 0.05). All other parameters lacked predictive information in our study. We conclude, that chronic immune activation is detectable in almost all HIV-1 seropositives. Chronic immune activation may be associated with HIV-1 replication and may contribute to the immunopathology of HIV-1 infection. © 1990.
引用
收藏
页码:75 / 79
页数:5
相关论文
共 50 条
  • [21] Uncoating of HIV-1 requires cellular activation
    Auewarakul, P
    Wacharapornin, P
    Srichatrapimuk, S
    Chutipongtanate, S
    Puthavathana, P
    VIROLOGY, 2005, 337 (01) : 93 - 101
  • [22] Urinary neopterin as a prognostic index of survival time in HIV-1 infection
    Rogstad, KE
    Morgan, L
    Hughes, J
    INTERNATIONAL JOURNAL OF STD & AIDS, 1998, 9 (06) : 326 - 329
  • [23] Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study
    Suhaib Hattab
    Amelie Guihot
    Marguerite Guiguet
    Slim Fourati
    Guislaine Carcelain
    Fabienne Caby
    Anne-Geneviève Marcelin
    Brigitte Autran
    Dominique Costagliola
    Christine Katlama
    BMC Infectious Diseases, 14
  • [24] Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study
    Hattab, Suhaib
    Guihot, Amelie
    Guiguet, Marguerite
    Fourati, Slim
    Carcelain, Guislaine
    Caby, Fabienne
    Marcelin, Anne-Genevieve
    Autran, Brigitte
    Costagliola, Dominique
    Katlama, Christine
    BMC INFECTIOUS DISEASES, 2014, 14
  • [25] Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV
    Toribio, Mabel
    Fitch, Kathleen V.
    Sanchez, Laura
    Burdo, Tricia H.
    Williams, Kenneth C.
    Sponseller, Craig A.
    Pate, Mary McCurdy
    Aberg, Judith A.
    Zanni, Markella V.
    Grinspoon, Steven K.
    AIDS, 2017, 31 (06) : 797 - 806
  • [26] Electronic transduction of HIV-1 drug resistance in AIDS patients
    Alfonta, L
    Blumenzweig, I
    Zayats, M
    Baraz, L
    Kotler, M
    Willner, I
    CHEMBIOCHEM, 2004, 5 (07) : 949 - 957
  • [27] Targeting HIV-1 innate immune responses therapeutically
    Ellegard, Rada
    Shankar, Esaki M.
    Larsson, Marie
    CURRENT OPINION IN HIV AND AIDS, 2011, 6 (05) : 435 - 443
  • [28] ASSOCIATION OF IMMUNE ACTIVATION WITH INTRAVENOUS HEROIN USE AND METHADONE TREATMENT IN HIV-1 SEROPOSITIVE AND SERONEGATIVE SUBJECTS
    DIFRANCO, MJ
    MARLINK, R
    HUNTER, DJ
    TOSTESON, T
    MAYER, K
    ESSEX, M
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1993, 6 (12) : 1297 - 1300
  • [29] Host genetic factors in susceptibility to HIV-1 infection and progression to AIDS
    Chatterjee, Koushik
    JOURNAL OF GENETICS, 2010, 89 (01) : 109 - 116
  • [30] Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment
    Hightower, George K.
    Wong, Joseph K.
    Letendre, Scott L.
    Umlauf, Anya A.
    Ellis, Ronald J.
    Ignacio, Caroline C.
    Heaton, Robert K.
    Collier, Ann C.
    Marra, Christina M.
    Clifford, David B.
    Gelman, Benjamin B.
    McArthur, Justin C.
    Morgello, Susan
    Simpson, David M.
    McCutchan, J. A.
    Grant, Igor
    Little, Susan J.
    Richman, Douglas D.
    Pond, Sergei L. Kosakovsky
    Smith, Davey M.
    VIROLOGY, 2012, 433 (02) : 498 - 505